openPR Logo
Press release

Global RNA Therapeutics Market 2020 Edition Report with Impact of COVID-19|Top Leaders- Alnylam Pharmaceuticals, Inc Dicerna Pharmaceuticals, Tekmira Pharmaceuticals, Benitec Biopharma

09-16-2020 11:19 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global RNA Therapeutics Market

Global RNA Therapeutics Market

Global RNA Therapeutics Market report identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the industry with analysis on vendors, geographical regions, types, and applications. This market study estimates the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. This report proves to be an indispensable document for every market enthusiast, policymaker, investor, and player. Global RNA Therapeutics Market research report is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis.

An excellent and precise market research report serves as a backbone for the business when it comes to thrive in the competition. Global RNA Therapeutics Market report offers a telescopic view of the competitive landscape to the client so that they can plan the strategies accordingly. This market research report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. This winning marketing report is presented to the clients with full commitment and best possible service is assured depending upon the requirements.

Market Analysis and Insights: Global RNA Therapeutics Market

RNA therapeutics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the genetic diseases, neurological disorders and advancement in the biotechnological sector are the factors responsible for the growth of this market

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rna-therapeutics-market&pm

Competitive Landscape and RNA therapeutics market Share Analysis

Global RNA therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to RNA therapeutics market.

The major players covered in the RNA therapeutics market are Quark, Alnylam Pharmaceuticals, Inc Dicerna Pharmaceuticals, Tekmira Pharmaceuticals, Benitec Biopharma, Sanofi, Ionis Pharmaceuticals, Silence Therapeutics, Cenix BioScience, Sirnaomics, CureVac AG, BioNTech SE, Arrowhead Pharmaceuticals, Inc, Arbutus Biopharma, Marina Biotech, Inc and among others.

Advancement in the treatment options to target specificity and selectivity drives the growth of RNA therapeutics market. Rapid adoption of newer formulations and novel drug delivery boost up the RNA therapeutics market growth. In addition, approval and launch of RNA therapeutics plays a major role in growth of market in the above forecasted period. Furthermore, special designation from the regulatory authority is one of the significant factors which are expected to drive the market growth.

RNA therapeutics is the new class of drugs that exert their effect by silencing a portion of RNA through the use of short interfering RNAs (siRNAs) or microRNAs (miRNAs) involved in causing the disease. RNA-based therapies such as antisense, siRNAs, aptamers, microRNA mimics/anti-miRs and synthetic mRNA have potential to treat a variety of chronic and rare diseases.

RNA therapeutics market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-rna-therapeutics-market&pm

Global RNA Therapeutics Market Scope and Market Size

The RNA therapeutics market is segmented on the basis of technologies, application, route of administration and end-users.

Based on technologies, the RNA therapeutics market is segmented into enabling technologies, enabled technologies. The enabling technologies are further categorized into microarray, labeling, purification, inhibition and others. The enabled technologies are further bifurcated into RNA interference (RNAi) technologies and RNA antisense technologies.
The application segment for RNA therapeutics market includes cardiovascular, oncology, infections, immunology, metabolic disorders and others.
On the basis of route of administration, RNA therapeutics market is segmented into oral, subcutaneous, intravenous, intramuscular and others.
Based on end-user, the substance abuse and addiction treatment market is segmented into hospitals, research organization, specialty clinics, diagnostic laboratory and others

Global RNA Therapeutics Market Country Level Analysis

The global RNA therapeutics market is analyzed and market size information is provided by country, technologies, application, route of administration and end-users as referenced above.

The countries covered in the RNA therapeutics market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America was the leading revenue contributor to the RNA therapeutics market due to high prevalence rate of chronic diseases, increasing adoption of novel drug delivery and potential players in the same geography while Asia- Pacific is expected to hold substantial growth due to the focus of various established market players to expand their presence in this particular region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

For More Insights Get FREE Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-rna-therapeutics-market&pm

Patient Epidemiology Analysis

Global RNA therapeutics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Key Development:

In August 2018, Alnylam Pharmaceuticals, Inc received an approval from the FDA for Onpattro (patisiran) contains a transthyretin-directed small interfering RNA for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. The approval of Onpattro, RNA based therapy offers patients an innovative treatment for their symptoms that targets the underlying basis of this disease.

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global RNA Therapeutics Market 2020 Edition Report with Impact of COVID-19|Top Leaders- Alnylam Pharmaceuticals, Inc Dicerna Pharmaceuticals, Tekmira Pharmaceuticals, Benitec Biopharma here

News-ID: 2135189 • Views: 157

More Releases from Data Bridge Market Research

Dental Radiology Equipment Market 2020 Segment Analysis By VATECH, Midmark Corpo …
Dental Radiology Equipment Market is expected to rise from its initial estimated value of USD 2.68 billion in 2018 to an estimated value of USD 5.86 billion by 2026, registering a CAGR of 10.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the global increase in diagnostics creating huge scope. Few of the major competitors currently working in the dental radiology equipment market are Danaher
Dental Prosthetics Market Future Scope By Zimmer Biomet, Danaher, Henry Schein, …
Dental Prosthetics Market report makes sure to include every opportunity, challenges, drivers, market structures, and competitive scene for the customers. Two of the major tools of market analysis used here are SWOT analysis and Porter’s Five Forces Analysis. In addition, it combines comprehensive market analysis with specific estimates and predictions to give total research solution, most prominent clearness for key basic choices. The report exhibits significant item advancements and tracks ongoing
Dental Infection Control Market Top Players Analysis: Henry Schein, Inc., GC Ame …
Dental Infection Control Market By Product (Consumables, Equipment), End User (Dental Hospitals, Dental Clinics, Dental Research Institutes and Academics, Dental Laboratories), Geography (North America, Europe, South America, Asia-Pacific, Middle-East) – Industry Trends & Forecast to 2026 Some of the major players operating in this market are 3M, Young Innovations, Inc., Kerr Corporation, Henry Schein, Inc., GC America Inc., A-dec Inc., Dentsply Sirona, COLTENE Group, Kol Al-Hamaya Factory, Medicom, Schulke & Mayr UK
Deep Brain Stimulation Systems Market Growth to 2027: Leading Players are NeuroP …
The global deep brain stimulation systems market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.5% in the forecast period of 2020 to 2027 and expected to reach USD 1,954.35 million by 2027 from USD 1,017.57 million in 2019. Rising demand for early and accurate disease diagnosis is the factor

All 5 Releases


More Releases for RNA

RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led